HL7 Care Plan (CP) Project Health Concerns – Risks – Goals in Care Plans April 2013 *C are Plan wiki:

Slides:



Advertisements
Similar presentations
Diabetes Overview Managing Diabetes in Primary Care.
Advertisements

TIME TO ACT Type 2 diabetes, the metabolic syndrome and cardiovascular disease in Europe CONTENTS Section One: Background to type 2 diabetes, the metabolic.
Diabetes Self Management Laura Wintersteen-Arleth, MN, RN,CDE
Adult Medical-Surgical Nursing Endocrine Module: DM Footcare and Patient Teaching Plan.
Chapter 06 6 Diabetes Albright C H A P T E R. Definition Diabetes mellitus –A group of metabolic diseases –Characterized by inability to produce sufficient.
Glucose Tolerance Test Diabetes Mellitus Dr. David Gee FCSN Nutrition Assessment Laboratory.
Pancreas & diabetes Željka Kušter Mentor: A. Žmegač Horvat.
Chronic Care Plan. Programme 1 2 Long-term complications Co-morbid conditions.
Diabetes Mellitus.
DIABETES MELLITUS TYPE II NON INSULIN DEPENDENT DIABETES (NIDDM)
Diabetes- Are You at Risk?
Looking after your diabetes Dr Gill Hood North Thames Clinical Research Network
Diabetes. How glucose gets into your body You eat. Glucose from the food gets into your bloodstream. Your pancreas produces a hormone called insulin.
Diabetes Mellitus: General information CDC 14.7 million Americans diagnosed (2004) Est. 5 million not diagnoses.
Dr Kiran Sodha Patient Participation Group October 2014
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Diabetes and PVD.
HL7 Care Plan (CP) Project Care Coordination Services Project Updates May 2013 – Atlanta Meeting Updates *C are Plan Project wiki:
With Open Eyes Presented by: Regina Weitzman, MD.
DIABETES Power over Diabetes Presented by: Regina Weitzman, MD.
FACTS At least 194 m people worldwide suffer from diabetes; this figure is likely to be more than double by 2030 At least 194 m people worldwide suffer.
Microvascular complications Diabetes Outreach (August 2011)
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
METABOLIC SYNDROME Dr Gerhard Coetzer. Complaint Thirsty all the time Urinating more than usual Blurred vision Tiredness.
Adult Medical-Surgical Nursing
Better Health. No Hassles. Type 2 Diabetes. Better Health. No Hassles. TYPE 2 DIABETES Chronic condition that affects the way your body metabolizes sugar.
Diabetes Mellitus Diabetes Mellitus is a group of metabolic diseases characterized by elevated levels of glucose in blood (hyperglycemia) Diabetes Mellitus.
Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University
Adult Medical-Surgical Nursing Endocrine Module: Longterm Complications of Diabetes Mellitus.
Nursing Care of Clients with Diabetes Mellitus.
Epidemiology of Diabetes Mellitus by Santi Martini Departemen of Epidemiology Faculty of Public Health University of Airlangga.
Diabetes. Diabetes mellitus (DM) is a common syndrome and caused by lack or decreased effectiveness of endogenous insulin Insulin is needed to facilitate.
Plasma Glucose. Glucose Glucose (MW: ) is a very important fuel source to generate universal energy molecules (ATP). Blood glucose regulation I-
KEY TERMS DX TESTS RISK FACTORS CANCER PATHOPHYS HODGE-
Diabetes: The Modern Epidemic Roy Buchinsky, MD Director of Wellness.
Complications Acute and Chronic. Complications  Acute: sudden onset usually reversible  Chronic: gradual onset can be irreversible.
DIABETES MELLITUS IN CHILDREN: CLINICAL FEATURES, DIAGNOSTICS AND TREATMENT Prof. H.A. Pavlyshyn.
By: Dr. Fatima Makee AL-Hakak University of kerbala College of nursing.
Glucose Control and Monitoring
Diabetes Mellitus By Harvi & Manpreet. What Is It?  complex metabolic disorder  elevated blood glucose concentration  secondary to resistance to action.
Diabetes mellitus “ Basic approach” Dr Sajith.V.S MBBS,MD (Gen Med )
Diabetes Leading Cause of Blindness 30. Diabetes- A chronic disease that affects the way body cells convert food into energy.
DIABETES Naturopathic Doctors Ontario. Insulin Resistance Insulin Insufficiency Pancreatic cell damage (auto-immune, viral infection) High Blood Sugar.
Course: Medical Biotechnology.  Metabolic and Multifactorial disease develops mostly due to deficiency of insulin. As a result high blood sugar will.
Prince Sattam Bin AbdulAziz University College Of Pharmacy Professor Mohammad Abd- elmotaal Mohammad Ruhal Ain, R Ph, PGDPRA, M Pharm Diabetes Mellitus.
Endocrine System Nursing Care for Diabetes Disorders.
Common Endocrine Disorders Dr Amanda Stewart Consultant Endocrinologist Tawam Hospital.
Diabetes Mellitus Ch 13 ~ Endocrine System Med Term.
Diabetes mellitus Under supervision d : Doaa Sabry Doha Al-badry Ahmed Okasha.
Dixie L. Thompson chapter 20 Exercise and Diabetes.
Homeostasis Anatomy and Physiology Unit 5 Sophie Bevan.
Diabetes. Objectives: Diabetes Mellitus (DM) Discuss the prevalence of diabetes in the U.S. Contrast the main types of diabetes. Describe the classic.
Acute Infections and Insulin Requirements In pre-diabetic individuals acute infections may induce a temporary state of diabetes requiring short-term insulin.
What is Diabetes? Definition: A disorder of metabolism where the pancreas produces little or no insulin or the cells do not respond to the insulin produced.
DAKTARI ANNETTE BALONGO. DIABETES DEFINATION Its is a metabolic disorder characterized by increase in blood sugar 1.Insulin resistance 2.Deficiency in.
Copyright © 2016, 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Chapter 64-Iggy Pg Care of Patients with Diabetes Mellitus.
DIABETES MELLITUS. Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, insulin action, or both. DM is associated.
Diabetes mellitus.
ЗАЛИВКА РИСУНКОМ.
Non-Communicable Diseases Unit Lesson 3
Jessica johnson, pharm. D.
Diabetes Health Status Report
HL7 Patient Care Work Group
Integrated approach of yoga therapy (IAYT) for Diabetic Participant Submitted by Sonu Maurya.
Diabetes Allison Ormond, RN Pamlico County Primary School.
FACTS At least 194 m people worldwide suffer from diabetes; this figure is likely to be more than double by 2030 Around 4 m deaths every year are related.
Diabetes.
Pharmaceutical care planning 2 Ola Ali Nassr
Srednja zdravstvena šola Izola
Presentation transcript:

HL7 Care Plan (CP) Project Health Concerns – Risks – Goals in Care Plans April 2013 *C are Plan wiki: Dr Stephen Chu (Chief Clinical Informatician & Terminologist, NEHTA, Australia) HL7 Patient Care Work Group To join the meeting: Phone Number: Participant Passcode: #

Page 2 Health condition, problems and goals Condition/Diagnosis (e.g. Type 2 Diabetes Mellitus) [a diagnosis often results in one or more problems for the patient] [Primary] Problem 1: inability to regulate blood glucose level Problem 4: weight loss (resulting from inability to process calorie from foods) Problem 5: polyphagia (resulting from hunger effect of increased insulin output to process high blood glucose) Problem 6: lethargy (resulting from inability to utilise glucose effectively) Problem 7: altered mental state (resulting from hyperglycaemia, ketoacidosis, etc) [agitation, unexplained irritability, inattention, or confusion] Problem 2: urinary problems (resulting from hyperglycaemia) [polyuria, nocturia] Problem 3: polydipsia (resulting from excessive urine output) Goal 1: relief acute symptoms [polyuria polydipsia lethargy altered mental state …]

Page 3 Problems, Goals and Interventions Diagnosis (e.g. Type 2 Diabetes Mellitus) [a diagnosis often results in one or more problems for the patient] [Primary] Problem 1: inability to regulate blood glucose level Problem 4: weight loss (resulting from inability to process calorie from foods) Problem 5: polyphagia (resulting from hunger effect of increased insulin output to process high blood glucose) Problem 6: lethargy (resulting from inability to utilise glucose effectively) Problem 7: altered mental state (resulting from hyperglycaemia, ketoacidosis, etc) [agitation, unexplained irritability, inattention, or confusion] Problem 2: urinary problems (resulting from hyperglycaemia) [polyuria, nocturia] Problem 3: polydipsia (resulting from excessive urine output) Goal 1: maintain effective blood glucose control [fasting = 4-6 mmol/litre] Goal 2: maintain HbA1C level =< 7% Intervention 1: diet control (diabetic diet) Intervention 2: medications Intervention 3: exercise (if overweight) Outcome measures daily BSL measures: pre-prandial reading 4-7mmol/l post-prandial reading <8.5 mmol/l HBA1C 3 monthly reading =<7%

Page 4 Modelling Risks Types:  Intrinsic  extrinsic Intrinsic  Risks that are consequential to a person’s health profile, condition or problems Extrinsic  Risks that are consequential to interventions designed to manage a person’s condition

Page 5 Intrinsic Risks: consequential to condition/problem  Care Plans needs to model/include two types of risks: o Risks that are consequential to health concerns/problems that trigger the instantiation of a care plan o These are the risks healthcare providers treat o Examples: Poorly controlled hyperlipidaemia Poorly controlled hyperglycaemia Smoking (health concern/problem) o Hyperlipidaemia as an intrinsic risk of Type 2 DM: Poorly controlled hyperlipidaemia in Type 2 DM significantly increased risks of CVS of a person This risk becomes an outbound risk to another care plan(s) instantiated to management the person with comorbidities such as hypertension and/or ischaemic heart disease

Page 6 Intrinsic Risks: consequential to problem Diagnosis (e.g. Type 2 Diabetes Mellitus) [a diagnosis often results in one or more problems for the patient] [Primary] Problem 1: inability to regulate blood glucose level Problem 4: weight loss (resulting from inability to process calorie from foods) Problem 5: polyphagia (resulting from hunger effect of increased insulin output to process high blood glucose) Problem 6: lethargy (resulting from inability to utilise glucose effectively) Problem 7: altered mental state (resulting from hyperglycaemia, ketoacidosis, etc) [agitation, unexplained irritability, inattention, or confusion] Risk 1: poor wound healing (resulting from impaired WBC, poor circulation from thickened blood vessels) [high risk of foot/toe ulcers and gangrene] ← intrinsic risk (consequential to Type 2 DM) Risk 2: increased infection (resulting from suppression of immune system from high glucose in tissues) [skin, urinary tract] ← intrinsic risk Risk 3: hyperlipidaemia ← intrinsic risk (can create outbound risks, e.g. increase CVS risks to those with family history) Risk 4: microangiopathy ← intrinsic risk Problem 2: urinary problems (resulting from hyperglycaemia) [polyuria, nocturia] Problem 3: polydipsia (resulting from excessive urine output)

Page 7 Extrinsic Risks: consequential to interventions  Extrinsic Risks: they are consequential to interventions implemented to treat/manage health concerns/problems  Examples: o Prolonged bleeding time (outside the optimal recommended range, e.g. INR >3.0) caused by anticoagulant therapy increasing the risk of internal haemorrhage o Lecukocytopenia caused by chemotherapy increasing the risk of infections o Suppression of prostacyclin by Cox-2 Inhibitor NSAID used in treatment of arthritic pain increasing the risks of heart attacks and stroke  In care plans, these risks may represent outbound risks other care plan instantiated to manage other comorbidities will need to be aware of o Arthritis care plan including Cox-2 inhibitor NSAID treatment presents outbound risk for care plan instantiated to manage CVS comorbidity of the same person

Page 8 Extrinsic Risks: consequential to interventions Diagnosis (e.g. Type 2 Diabetes Mellitus) [a diagnosis often results in one or more problems for the patient] [Primary] Problem 1: inability to regulate blood glucose level Risk 1: poor wound healing (resulting from impaired WBC, poor circulation from thickened blood vessels) [high risk of foot/toe ulcers and gangrene] Risk 2: increased infection (resulting from suppression of immune system from high glucose in tissues) [skin, urinary tract] Risk 3: cardiovascular complications [e.g. hypertension, ischaemia heart disease] Risk 4: microangiopathy [e.g. retinopathy, nephropathy, peripheral neuropathy] Risk 5: eye complications [e.g. cataract] Is outbound CVS risks affecting CVS care plan for same person with CVS comorbidity (or increase CVS risk for those with positive family history of CVS problems) Is an outbound risks affecting arthritis care plan for same person (esp when using cox-2 inhibitor analgesics Is an outbound risks affecting renal infections management care plan of same person (or when need to use aminoglycoside antibiotics to treat infections) Is an outbound risks for patient with increased exposure to sunlights [agriculture, forestry, fishing, construction industries]

Page 9 Inbound and Outbound risks An outbound risk of one care plan becomes inbound risks of another for the same person